Paxman AB (ST:PAX) — Market Cap & Net Worth
Market Cap & Net Worth: Paxman AB (PAX)
Paxman AB (ST:PAX) has a market capitalization of $147.27 Million (Skr1.37 Billion) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #17818 globally and #304 in its home market, demonstrating a -0.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Paxman AB's stock price Skr58.80 by its total outstanding shares 23273416 (23.27 Million). Also see PAX total asset value for a full breakdown of the balance sheet.
Paxman AB Market Cap History: 2017 to 2026
Paxman AB's market capitalization history from 2017 to 2026. Data shows growth from $48.84 Million to $147.27 Million (19.93% CAGR). Also see PAX cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Paxman AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.23 Billion | 0.97% | #25 of 281 |
Weight: Paxman AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Paxman AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Paxman AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Paxman AB stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.65x
Paxman AB's market cap is 0.65 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.09x
Paxman AB's market cap is 4.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $48.84 Million | $31.33 Million | -$6.72 Million | 1.56x | N/A |
| 2018 | $60.36 Million | $58.02 Million | -$7.10 Million | 1.04x | N/A |
| 2019 | $150.28 Million | $85.28 Million | $2.76 Million | 1.76x | 54.53x |
| 2020 | $63.62 Million | $78.05 Million | -$19.19 Million | 0.82x | N/A |
| 2021 | $162.80 Million | $96.20 Million | -$12.78 Million | 1.69x | N/A |
| 2022 | $107.95 Million | $156.75 Million | -$10.32 Million | 0.69x | N/A |
| 2023 | $92.17 Million | $210.12 Million | $8.33 Million | 0.44x | 11.06x |
| 2024 | $164.30 Million | $253.01 Million | $40.20 Million | 0.65x | 4.09x |
Competitor Companies of PAX by Market Capitalization
Companies near Paxman AB in the global market cap rankings as of September 19, 2026. Review PAX tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Paxman AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Paxman AB Historical Marketcap From 2017 to 2026
Between 2017 and today, Paxman AB's market cap moved from $48.84 Million to $ 147.27 Million, with a yearly change of 19.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr147.27 Million | +4.63% |
| 2025 | Skr140.76 Million | -14.33% |
| 2024 | Skr164.30 Million | +78.26% |
| 2023 | Skr92.17 Million | -14.62% |
| 2022 | Skr107.95 Million | -33.69% |
| 2021 | Skr162.80 Million | +155.91% |
| 2020 | Skr63.62 Million | -57.67% |
| 2019 | Skr150.28 Million | +148.96% |
| 2018 | Skr60.36 Million | +23.59% |
| 2017 | Skr48.84 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Paxman AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $147.27 Million USD |
| MoneyControl | $147.27 Million USD |
| MarketWatch | $147.27 Million USD |
| marketcap.company | $147.27 Million USD |
| Reuters | $147.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Paxman AB
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of … Read more